NCT06418165 Vienna Hypothermic Oxygenated Machine Perfusion Study
| NCT ID | NCT06418165 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of Vienna |
| Condition | End Stage Liver Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2018-01-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2018-01-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this observational cohort study data on all patients undergoing liver transplantation after hypothermic oxygenated machine perfusion at Medical University of Vienna will be prospectively recorded. Investigation of short- and long-term outcome in this cohort will be conducted.
Eligibility Criteria
Inclusion Criteria: * patients undergoing liver transplantation with the use of hypothermic oxygenated machine perfusion * age ≥ 18 years Exclusion Criteria: * pregnancy * partial grafts * the anatomical integrity of the liver is not preserved in a way that makes the perfusion of the liver possible
Contact & Investigator
Gabriela A Berlakovich, Prof, MD
STUDY CHAIR
Medical University of Vienna, Division of Transplantation
Frequently Asked Questions
Who can join the NCT06418165 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying End Stage Liver Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06418165 currently recruiting?
Yes, NCT06418165 is actively recruiting participants. Contact the research team at david.pereyra@muv.ac.at for enrollment information.
Where is the NCT06418165 trial being conducted?
This trial is being conducted at Vienna, Austria.
Who is sponsoring the NCT06418165 clinical trial?
NCT06418165 is sponsored by Medical University of Vienna. The principal investigator is Gabriela A Berlakovich, Prof, MD at Medical University of Vienna, Division of Transplantation. The trial plans to enroll 500 participants.